IBRUTIX 140 MG
Product Description: Ibrutix (Ibrutinib) is a kinase inhibitor indicated for the treatment of patients with: Mantle Cell Lymphoma (MCL) who
IBRUXEN 140 MG
Ibruxen Capsule Ibrutinib 140 mg Everest Pharmaceuticals Ltd. Indications Mantle Cell Lymphoma: Ibrutinib is indicated for the treatment of patients with
JUPARIB 150 MG
Juparib Tablet Olaparib 150 mg Julphar Bangladesh Ltd. Also available as: 100 mg Indications Breast Cancer: Olaparib is indicated as monotherapy
LENVAXEN 10 MG
DESCRIPTION Lenvaxen Lenvatinib 4 mg & 10 mg COMPOSITION LENVAXEN 4 capsules: Each capsule contains Lenvatinib Mesylate INN equivalent to
LENVAXEN 4 MG
DESCRIPTION Lenvaxen Lenvatinib 4 mg & 10 mg COMPOSITION LENVAXEN 4 capsules: Each capsule contains Lenvatinib Mesylate INN equivalent to
LYNIB 100 MG
LYNIB MEDICINE 100mg Olaparib treats Ovarian cancer Brand name: Lynib Active ingredient: Olparib Content: 100mg Form: Capsules Package: 1 box of
MEZOXIA 150 MG
MEZOXIA 150 MG/*54745756836*/
NIRANIB 100 MG
DESCRIPTION Niranib Niraparib 100 mg Everest Pharmaceuticals Ltd. Bangladesh COMPOSITION NIRANIB Capsule: Each capsule contains Niraparib Tosylate Monohydrate INN equivalent
OBELIVA 10 MG
Obeliva Tablet Obeticholic Acid 5 mg Everest Pharmaceuticals Ltd. 10 mg Indications Obeticholic Acid is indicated for the treatment of primary
OBELIVA 5 MG
Obeliva Tablet Obeticholic Acid 5 mg Everest Pharmaceuticals Ltd. 10 mg Indications Obeticholic Acid is indicated for the treatment of primary
OLANIB 150 MG
DESCRIPTION Olanib (Olaparib) Olanib is used for the returning treatment of some types of ovarian cancer in patients who have